Ads

 

Ads

 

Ads

 

World Top 100 Pharmaceutical Companies List by Market Cap as of August 2026

World Top 100 Pharmaceutical Companies List by Market Cap as of August 2026, World Biggest 100 Pharmaceutical Companies by Market Cap, World Largest 100 Pharmaceutical Companies in the World by market cap as of August 2026.

Metatag Title
World Top Pharmaceutical Companies in 2026
Metatag Abstract
World Top Pharmaceutical Companies by Market Cap in 2026, World Largest Pharmaceutical Companies by Market Cap in 2026.
  1. Baxter International

    World Rank (Aug-2026)
    1,691
    Market Cap (Aug-2026)
    13.819 Billion USD
    World Rank (Jan-05-2024)
    929
    Market Cap (Jan-05-2024)
    19.598 Billion USD
    World Rank (Jul-30-2023)
    791
    Market Cap (Jul-30-2023)
    23.780 Billion USD
    World Rank (Dec-25-2022)
    667
    Market Cap (Dec-25-2022)
    25.292 Billion USD
    World Rank (Jan-07-2022)
    453
    Market Cap (Jan-07-2022)
    43.79 Billion USD
    Annual Revenue in USD
    11,244 Million USD
    Annual Operating Income in USD
    -308 Million USD
    Annual Net Income in USD
    -957 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Stock Category
    Company Profile

    BAXTER INTERNATIONAL develops Healthcare Products, Medical Devices with headquarters is in USA. Develops healthcare products related to kidney diseases and immunity disorders.

    BAXTER INTERNATIONAL PRODUCTS:

  2. Charles River Laboratories International

    World Rank (Aug-2026)
    1,745
    Market Cap (Aug-2026)
    13.369 Billion USD
    World Rank (Jan-05-2024)
    1,471
    Market Cap (Jan-05-2024)
    11.492 Billion USD
    World Rank (Jul-30-2023)
    1,589
    Market Cap (Jul-30-2023)
    10.773 Billion USD
    World Rank (Dec-25-2022)
    1,409
    Market Cap (Dec-25-2022)
    11.117 Billion USD
    World Rank (Jan-07-2022)
    1,223
    Market Cap (Jan-07-2022)
    16.59 Billion USD
    Annual Revenue in USD
    4,015 Million USD
    Annual Operating Income in USD
    25 Million USD
    Annual Net Income in USD
    -144 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Stock Category
    Company Profile

    Charles River Laboratories is a Healthcare and pharmaceutical company. The company products and services are Research animals models, genetically engineered model and services, animal health, surveillance, surgery and precondition service, generic testing services and Insourcing solutions. The headquarters is in USA.

    The company currently operated 110 facilities in 20 countries.

    Facts About Company

    Charles River Laboratories annual revenue generated for period ending Dec-2022 was 3,976 million USD.

    Charles River Laboratories annual net income generated for period ending Dec-2022 was 486 million USD.

    Charles River Laboratories annual revenue generated for period ending Dec-2021 was 3,540 million USD.

    Charles River Laboratories annual net income generated for period ending Dec-2021 was 391 million USD.

  3. CSPC Pharmaceutical Group

    World Rank (Aug-2026)
    1,746
    Market Cap (Aug-2026)
    13.368 Billion USD
    World Rank (Jan-05-2024)
    1,527
    Market Cap (Jan-05-2024)
    10.927 Billion USD
    World Rank (Jul-30-2023)
    1,676
    Market Cap (Jul-30-2023)
    9.996 Billion USD
    World Rank (Dec-25-2022)
    1,250
    Market Cap (Dec-25-2022)
    12.768 Billion USD
    World Rank (Jan-07-2022)
    1,485
    Market Cap (Jan-07-2022)
    13.43 Billion USD
    Annual Revenue in USD
    4,336 Million USD
    Annual Operating Income in USD
    947 Million USD
    Annual Net Income in USD
    854 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile

    CSPC Pharmaceutical Group Limited is a pharmaceutical group in China. CSPC mainly owns two business segments of finished drugs and bulk drugs. Headquarters is in China.

  4. Yunnan Baiyao Group

    World Rank (Aug-2026)
    1,770
    Market Cap (Aug-2026)
    13.096 Billion USD
    World Rank (Jan-05-2024)
    1,396
    Market Cap (Jan-05-2024)
    12.384 Billion USD
    World Rank (Jul-30-2023)
    1,300
    Market Cap (Jul-30-2023)
    13.647 Billion USD
    World Rank (Dec-25-2022)
    1,130
    Market Cap (Dec-25-2022)
    14.223 Billion USD
    World Rank (Jan-07-2022)
    1,009
    Market Cap (Jan-07-2022)
    20.58 Billion USD
    Annual Revenue in USD
    5,105 Million USD
    Annual Operating Income in USD
    582 Million USD
    Annual Net Income in USD
    420 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Pharmaceutical Company with headquarters is in China. Manufactures medicines and chemicals.
  5. BioMarin Pharmaceutical

    World Rank (Aug-2026)
    1,775
    Market Cap (Aug-2026)
    13.039 Billion USD
    World Rank (Jan-05-2024)
    985
    Market Cap (Jan-05-2024)
    18.409 Billion USD
    World Rank (Jul-30-2023)
    1,112
    Market Cap (Jul-30-2023)
    16.444 Billion USD
    World Rank (Dec-25-2022)
    863
    Market Cap (Dec-25-2022)
    19.391 Billion USD
    World Rank (Jan-07-2022)
    1,308
    Market Cap (Jan-07-2022)
    15.47 Billion USD
    Annual Revenue in USD
    3,221 Million USD
    Annual Operating Income in USD
    409 Million USD
    Annual Net Income in USD
    349 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Biomarin Pharmaceutical is Pharmaceutical and Biotechnology Company with headquarters is in California, USA.

    It develops innovate therapies and life-threatening rare diseases and medical conditions.It consists of seven commercial products for the treatment of various diseases.

    As on 2022, Biomarin Pharmaceutical has 3,082 employees.

    Biomarin Pharmaceutical annual revenue generated for period ending Dec-2022 was 2,096 million USD.

  6. Orion Oyj

    World Rank (Aug-2026)
    1,776
    Market Cap (Aug-2026)
    13.039 Billion USD
    World Rank (Jan-05-2024)
    2,507
    Market Cap (Jan-05-2024)
    6.095 Billion USD
    World Rank (Jul-30-2023)
    2,750
    Market Cap (Jul-30-2023)
    5.458 Billion USD
    World Rank (Dec-25-2022)
    1,852
    Market Cap (Dec-25-2022)
    7.917 Billion USD
    World Rank (Jan-07-2022)
    2,972
    Market Cap (Jan-07-2022)
    5.69 Billion USD
    Annual Revenue in USD
    1,477 Million USD
    Annual Operating Income in USD
    481 Million USD
    Annual Net Income in USD
    385 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Orion Corporation is a Pharmaceutical company. It is investing EUR 17 million in its production facilities in Turku. The company is investing in a new packaging line for anticancer drugs and expanding its cream manufacturing department. It net sales in 2019 were EUR 1,051 million and the company employed about 3,300 employees at the end of the year. The headquarters is in Finland.
  7. Zhejiang Nhu Company

    World Rank (Aug-2026)
    1,822
    Market Cap (Aug-2026)
    12.722 Billion USD
    World Rank (Jan-05-2024)
    2,123
    Market Cap (Jan-05-2024)
    7.454 Billion USD
    World Rank (Jul-30-2023)
    2,187
    Market Cap (Jul-30-2023)
    7.204 Billion USD
    World Rank (Dec-25-2022)
    1,803
    Market Cap (Dec-25-2022)
    8.216 Billion USD
    World Rank (Jan-07-2022)
    1,617
    Market Cap (Jan-07-2022)
    11.98 Billion USD
    Annual Revenue in USD
    2,233 Million USD
    Annual Operating Income in USD
    624 Million USD
    Annual Net Income in USD
    507 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile
    Zhejiang NHU Company is a functional chemical industries company including nutrition and health, personal and home care, transportation, environmental protection and new energy. It specialized in functional chemicals with an emphasis on nutritional chemicals, aroma chemicals and polymers. The headquarters is in China.
  8. Sino Biopharmaceutical

    World Rank (Aug-2026)
    1,827
    Market Cap (Aug-2026)
    12.683 Billion USD
    World Rank (Jan-05-2024)
    2,021
    Market Cap (Jan-05-2024)
    7.944 Billion USD
    World Rank (Jul-30-2023)
    1,899
    Market Cap (Jul-30-2023)
    8.629 Billion USD
    World Rank (Dec-25-2022)
    1,459
    Market Cap (Dec-25-2022)
    10.655 Billion USD
    World Rank (Jan-07-2022)
    1,423
    Market Cap (Jan-07-2022)
    14.15 Billion USD
    Annual Revenue in USD
    4,026 Million USD
    Annual Operating Income in USD
    844 Million USD
    Annual Net Income in USD
    356 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    SINO BIOPHARMACEUTICAL is BioPharmaceutical company with headquarters is in Hong Kong. The products include a variety of biological drugs and chemical drugs, and are in an advantageous position in many potential therapeutic fields such as liver disease, tumor, cardiovascular and cerebrovascular disease, orthopedics, digestive system, anti-infection and respiratory diseases.
  9. Recordati Industria Chimica E Farmaceutica

    World Rank (Aug-2026)
    1,834
    Market Cap (Aug-2026)
    12.642 Billion USD
    World Rank (Jan-05-2024)
    1,524
    Market Cap (Jan-05-2024)
    10.987 Billion USD
    World Rank (Jul-30-2023)
    1,604
    Market Cap (Jul-30-2023)
    10.629 Billion USD
    World Rank (Dec-25-2022)
    1,742
    Market Cap (Dec-25-2022)
    8.558 Billion USD
    World Rank (Jan-07-2022)
    1,552
    Market Cap (Jan-07-2022)
    12.71 Billion USD
    Annual Revenue in USD
    2,043 Million USD
    Annual Operating Income in USD
    545 Million USD
    Annual Net Income in USD
    344 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Recordati Industria Chimica e Farmaceutica is a Pharmaceutical Multinational company. The company is a leader in the treatment of rare diseases and orphan drugs, has successfully implemented its strategy of establishing a direct presence in the main markets of all continents as per 2019. It is having more than 4,300 employees, which is dedicated to research, development, production and marketing of pharmaceutical products, consolidated revenues in 2019 were € 1,481.8 million, operating profit was € 465.3 million and net income was € 368.9 million. The headquarters is in Italy.

  10. Zhangzhou Pientzehuang Pharmaceutical. Ltd

    World Rank (Aug-2026)
    1,849
    Market Cap (Aug-2026)
    12.518 Billion USD
    World Rank (Jan-05-2024)
    914
    Market Cap (Jan-05-2024)
    20.016 Billion USD
    World Rank (Jul-30-2023)
    770
    Market Cap (Jul-30-2023)
    24.483 Billion USD
    World Rank (Dec-25-2022)
    673
    Market Cap (Dec-25-2022)
    25.005 Billion USD
    World Rank (Jan-07-2022)
    549
    Market Cap (Jan-07-2022)
    37.28 Billion USD
    Annual Revenue in USD
    1,216 Million USD
    Annual Operating Income in USD
    400 Million USD
    Annual Net Income in USD
    346 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Zhangzhou Pien Tze Huang Pharmaceutical Co Ltd is a Pharmaceutical company. The company has 34 holding subsidiaries, 8 joint stock companies and 4 industry funds with more than 2,100 employees. The headquarters is in China.

Share

Ads